Ajanta Pharma USA recalls

Ajanta Pharma USA has 4 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 7 Oct 2026. 4 are still ongoing. 4 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls4since 2026

Last 12 months4reported

Class I00% of total

Ongoing4latest 7 Oct 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 1 1 0Aug 1 1

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why ajanta pharma usa is recalled

Product types

Cholesterol Medication125%

Brands

By year

20264100%

Ongoing ajanta pharma usa recalls

4 active

Reported	Class	Recall	Company	Reason	Where
7 Oct 2026Drug	CLASS II	Ranolazine Extended-Release Tablets, 1000 mg recalledRanolazine	Ajanta Pharma USA	Potency & Assay	Nationwide
16 Sep 2026Drug	CLASS III	Fluphenazine Hydrochloride Tablets, USP, 1mg recalledFluphenazine Hydrochloride	Ajanta Pharma USA	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Fenofibrate Capsules, USP 200 mg recalled by Ajanta Pharma USAFenofibrate	Ajanta Pharma USA	Manufacturing (CGMP) Deviations	Nationwide
24 Jun 2026Drug	CLASS II	Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole	Ajanta Pharma USA	Packaging Defects	Nationwide

All ajanta pharma usa recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
7 Oct 2026Drug	CLASS II	Ranolazine Extended-Release Tablets, 1000 mg recalledRanolazine	Ajanta Pharma USA	Potency & Assay	Nationwide
16 Sep 2026Drug	CLASS III	Fluphenazine Hydrochloride Tablets, USP, 1mg recalledFluphenazine Hydrochloride	Ajanta Pharma USA	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Fenofibrate Capsules, USP 200 mg recalled by Ajanta Pharma USAFenofibrate	Ajanta Pharma USA	Manufacturing (CGMP) Deviations	Nationwide
24 Jun 2026Drug	CLASS II	Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole	Ajanta Pharma USA	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.